Comparison of multiple gene expression platforms for measuring a bladder cancer hypoxia signature
Authors:
- 20 June 2022
- journal article
- research article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 26 (2) , 1-8
Abstract
Tumour hypoxia status provides prognostic information and predicts response to hypoxia‑modifying treatments. A previous study by our group derived a 24‑gene signature to assess hypoxia in bladder cancer. The objectives of the present study were to compare platforms for generating signature scores, identify cut‑off values for prospective studies, assess intra‑tumour heterogeneity and confirm hypoxia relevance. Briefly, RNA was extracted from prospectively collected diagnostic biopsies of muscle invasive bladder cancer (51 patients), and gene expression was measured using customised Taqman Low Density Array (TLDA) cards, NanoString and Clariom S arrays. Cross‑platform transferability of the gene signature was assessed using regression and concordance analysis. The cut‑off values were the cohort median expression values. Intra‑ and inter‑tumour variability were determined in a retrospective patient cohort (n=51) with multiple blocks (2‑18) from the same tumour. To demonstrate relevance, bladder cancer cell lines were exposed to hypoxia (0.1% oxygen, 24 h), and extracted RNA was run on custom TLDA cards. Hypoxia scores (HS) values showed good agreement between platforms: Clariom S vs. TLDA (r=0.72, Pin vitro.Keywords
This publication has 24 references indexed in Scilit:
- Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233Journal of Clinical Oncology, 2014
- NIMRAD – A Phase III Trial to Investigate the Use of Nimorazole Hypoxia Modification with Intensity-modulated Radiotherapy in Head and Neck CancerClinical Oncology, 2014
- Excess glucose induces hypoxia-inducible factor-1α in pancreatic cancer cells and stimulates glucose metabolism and cell migrationCancer Biology & Therapy, 2013
- Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinomaEuropean Journal of Cancer, 2013
- mRNA transcript quantification in archival samples using multiplexed, color-coded probesBMC Biotechnology, 2011
- Radiotherapy With Concurrent Carbogen and Nicotinamide in Bladder CarcinomaJournal of Clinical Oncology, 2010
- High glucose concentrations attenuate hypoxia-inducible factor-1α expression and signaling in non-tumor cellsExperimental Cell Research, 2010
- Heterogeneity and Power in Clinical Biomarker StudiesJournal of Clinical Oncology, 2009
- Direct multiplexed measurement of gene expression with color-coded probe pairsNature Biotechnology, 2008
- Survival Analysis With Heterogeneous Covariate Measurement ErrorJournal of the American Statistical Association, 2004